IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
IBISWorld's research coverage on the Medical Laboratory Services procurement and pricing environment in the United States includes market dynamics, buyer power scores, supply chain vendors with pricing trends and forecasts.
This procurement coverage of the Medical Laboratory Services market in the United States includes Calcium Testing, Cholesterol Testing, Complete Blood Count (CBC) Panel, Hepatitis B Testing, HIV Testing, Immunoglobulin Testing, Insulin Testing, Lipid Panel, Urinalysis and Vitamin D Testing. Standard coding in this coverage includes ISIC-869-Other human health activities, NACE-86.90-Other Human Health Activities, NAICS-621510-Medical and diagnostic laboratories and UNSPSC-85121800-Medical laboratories.
Common market terminology included in the Medical Laboratory Services procurement coverage includes Capitated Contracts (Contracts that allow a client to pay a flat fee per member per month, regardless of the types and numbers of tests performed.), Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) (CRISPR technology is used for gene editing and is a diagnostic tool to test target regions in a DNA sequence for mutations.), Genomics (The study of DNA, genes, and chromosomes.), Managed Care Organization (MCO) (Healthcare providers that use a variety of techniques to reduce healthcare costs. MCOs include network-based hospitals.), Prognostic Test (A test used to evaluate the probability of a patient developing a disease or experiencing a medical condition.), Requisitions (Test requests, including body fluid and tissue sample analysis.) and Waived Test (Medical tests that are exempted from certain regulatory standards for the sake of timely and appropriate medical treatment, especially for patients with geographical or equipment constraints.).
The top companies covered in the Medical Laboratory Services procurement report as suppliers are Neogenomics Inc., Opko Health, Inc., Myriad Genetics Inc., Lenco Diagnostics Laboratories Inc. and Sonic Healthcare Limited.
The Opportunity Assessment chapter provides a comprehensive market analysis of the Medical Laboratory Services market in the United States category, including buyer power scoring, market pricing trends, vendor landscape, cost structure, and strategic negotiation levers.
The market pricing trends include the Market Price (2026) per requisition, a five year price forecast and a supply chain risk score. Vendor coverage includes a market share and cost structure breakdown.
Analysis includes a comprehensive SWOT analysis of and recent developments impacting the Medical Laboratory Services market environment.
The Buyer Power Score chapter assesses key components impacting Medical Laboratory Services procurement including the recent price trend, forecast price trend, availability of substitutes, switching costs, product specialization, average vendor risk, market share concentration, supply chain risk, price driver volatility and recent price volatility.
These components generate a Buyer Power Score that ranges from -5 (strongly favoring sellers) to +5 (strongly favoring buyers) plus a recommended strategy for procurement specialists.
The Price Environment chapter covers detailed pricing analysis and datasets on Medical Laboratory Services market environment. This includes insights into market pricing Market Price (2026), price forecasts, volatility, specialization, substitutes and switching costs.
Datasets in the Price Environment chapter include vendor cost structure, breakdowns of wage rates by geography and specialty, key external economic and labor drivers impacting the market and market pricing models.
The Supply Chain & Vendors chapter covers the concentration, risk and diversity of the Medical Laboratory Services market. This includes datasets on the market’s top suppliers, detailed analysis on the key sourcing risks and supply chain dynamics, with environmental, social and governance (ESG) considerations and scores.
The Business Requirements chapter covers vendor relationships, qualifications, service level agreements and key performance indicators. These inputs provide insight into the planning process through the buying lead time, vendor relationship and vendor qualifications. The sourcing process include key RFP elements like an organizational overview, project budget, selection criteria, project schedule, proposal format, inventory control, cost containment, regulation, quality control, distribution and key contract clauses.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
The 2026 benchmark market price for Medical Laboratory Services is $7.89 per requisition. Prices have increased at a CAGR of 2.25 from 2023-26.
The top vendors in the Medical Laboratory Services market include Neogenomics Inc., Opko Health, Inc., Myriad Genetics Inc., Lenco Diagnostics Laboratories Inc. and Sonic Healthcare Limited.
The top industries supplying the Medical Laboratory Services market are Chemical Wholesaling in the US, Inorganic Chemical Manufacturing in the US, Organic Chemical Manufacturing in the US, Computer & Packaged Software Wholesaling in the US, Computer Manufacturing in the US, Couriers & Local Delivery Services in the US, Gasoline & Petroleum Wholesaling in the US, Laboratory Supply Wholesaling in the US and Glass Product Manufacturing in the US.
Low supplier concentration strengthens negotiation leverage and contract flexibility for buyers . The medical laboratory service market exhibits low market share concentration, allowing buyers to choose from a wide array of suppliers without reliance on a few dominant vendors. This fragmented environment fosters price competition, frequent innovation, and customization. Procurement teams can leverage this by running competitive bid processes, negotiating robust price and service terms, and switching suppliers with minimal switching costs, giving buyers significantly enhanced contract flexibility and ongoing cost optimization opportunities.
The type of test significantly affects pricing in medical laboratory services, as routine tests like complete blood counts and urinalysis typically cost less due to their standardized nature and high volume, while nonroutine tests such as genetic or esoteric tests are priced higher due to their complexity, specialized equipment, and lower demand. Pricing is often measured by factors such as test complexity, required technology, and the expertise needed for interpretation, reflecting both the direct costs of materials and the indirect costs of skilled labor and equipment maintenance.